课题基金 / 基金详情

项目摘要

项目成果

Padma Rajagopal的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
For this pilot study, 21 patients were identified from the LFS natural history cohort in DCEG with available blood samples and no known TP53 mutation. Familial relationships and ties have been characterized for any variants of interest that are identified. These patients are currently undergoing long-read DNA from blood (collaborating with Michael Dean, PhD in DCEG for sequencing interpretation, Misha Kolmogorov, PhD in CCR for computational assessment) and whole-transcriptome RNA-seq (including splice-site assessment and relative gene-expression levels).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Leveraging RNA and synthetic lethality in germline BRCA-mut breast cancer
  • 批准号:
    10926478
  • 项目类别:
  • 资助金额:
    $17.14万
  • 财政年份:
    --
  • 负责人:
    Padma Rajagopal
  • 依托单位:
Germline-Somatic Interactions and Association with Treatment Response in Cancer
  • 批准号:
    10926516
  • 项目类别:
  • 资助金额:
    $8.57万
  • 财政年份:
    --
  • 负责人:
    Padma Rajagopal
  • 依托单位:
Identifying synthetic lethal targets in metastatic triple negative breast cancer
  • 批准号:
    10487156
  • 项目类别:
  • 资助金额:
    $1.46万
  • 财政年份:
    --
  • 负责人:
    Padma Rajagopal
  • 依托单位:
Identifying Treatment Options using RNA-Based Synthetic Lethality and Rescue
  • 批准号:
    10926479
  • 项目类别:
  • 资助金额:
    $17.14万
  • 财政年份:
    --
  • 负责人:
    Padma Rajagopal
  • 依托单位:
海外基金